Nina I. Zhernakova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Nina I. Zhernakova has a total of 183 co-authors. Here are the top co-authors by number of shared publications:
- Ol'Ga A. Osipova
Belgorod State National Research University
7 shared publications - Artem V. Volnukhin
I.M. Sechenov First Moscow State Medical University (Sechenov University)
4 shared publications - Elena Olegovna Samokhina
I.M. Sechenov First Moscow State Medical University (Sechenov University)
4 shared publications - Svetlana Sergeevna Bunova
Belgorod State National Research University
4 shared publications - Tatiana E. Morozova
Sechenov First Moscow State Medical University
4 shared publications - Tatyana E. Pomytkina
Kemerovo State Medical University
4 shared publications
Latest Publications
- Open Access
- 30 September 2026
- Published by ECO-Vector LLC (Publications) in Russian Family Doctor
- Vol. 30 (3) , 5-14
Gut microbiome as a predictor of long-term abdominal outcomes of COVID-19
Post-COVID syndrome with persistent abdominal disorders is a significant medical and social problem, but the prognostic criteria for the development of chronic intestinal dysfunction are not sufficiently systematized. This review substantiates the concept of the intestinal microbiome as a promising integral predictive marker for the long-term gastrointestinal outcomes of COVID-19. Based on the analysis of 40 sources using the PRISMA methodology, the pathogenetic mechanisms of virus-induced dysbiosis have been systematized, including the blockade of the APF2–B⁰AT1 (sodium-dependent neutral amino acid transporter B(0)AT1, SLC6A19) complex, tryptophan deficiency, and inhibition of short-chain fatty acid production. It has been shown that the characteristic taxonomic shifts—a decrease in Faecalibacterium prausnitzii, Bifidobacterium spp., and Bacteroides spp., and an expansion of Ruminococcus gnavus and Enterococcus spp.— persist for more than 12 months and correlate with the frequency of post-COVID irritable bowel syndrome. Quantitative threshold predictive values have been determined: F. prausnitzii below 105 CFU/g, calprotectin above 100 μg/g, Shannon index less than 3.0. Three prognostic trajectories of microbiota recovery (restorative, stable-dysbiotic, and late dysbiotic) have been identified, and differential diagnostic microbiome patterns that distinguish post-COVID irritable bowel syndrome from the onset of inflammatory bowel diseases have been presented. A practical algorithm for monitoring convalescents has been substantiated, including early screening on day 30, risk stratification, and targeted correction (calcium butyrate, synbiotics).
- 30 September 2026
- Published by ECO-Vector LLC (Publications) in Russian Family Doctor
- Vol. 30 (3) , 5-14
Open AccessGut microbiome as a predictor of long-term abdominal outcomes of COVID-19
Post-COVID syndrome with persistent abdominal disorders is a significant medical and social problem, but the prognostic criteria for the development of chronic intestinal dysfunction are not sufficiently systematized. This review substantiates the concept of the intestinal microbiome as a promising integral predictive marker for the long-term gastrointestinal outcomes of COVID-19. Based on the analysis of 40 sources using the PRISMA methodology, the pathogenetic mechanisms of virus-induced dysbiosis have been systematized, including the blockade of the APF2–B⁰AT1 (sodium-dependent neutral amino acid transporter B(0)AT1, SLC6A19) complex, tryptophan deficiency, and inhibition of short-chain fatty acid production. It has been shown that the characteristic taxonomic shifts—a decrease in Faecalibacterium prausnitzii, Bifidobacterium spp., and Bacteroides spp., and an expansion of Ruminococcus gnavus and Enterococcus spp.— persist for more than 12 months and correlate with the frequency of post-COVID irritable bowel syndrome. Quantitative threshold predictive values have been determined: F. prausnitzii below 105 CFU/g, calprotectin above 100 μg/g, Shannon index less than 3.0. Three prognostic trajectories of microbiota recovery (restorative, stable-dysbiotic, and late dysbiotic) have been identified, and differential diagnostic microbiome patterns that distinguish post-COVID irritable bowel syndrome from the onset of inflammatory bowel diseases have been presented. A practical algorithm for monitoring convalescents has been substantiated, including early screening on day 30, risk stratification, and targeted correction (calcium butyrate, synbiotics).
- Open Access
- 15 June 2026
- Published by ECO-Vector LLC (Publications) in Russian Family Doctor
- Vol. 30 (2) , 21-34
The use of modern cancer screening methods in primary healthcare
Cancer treatment advances are clear, but screening potential remains underutilized due to deficiencies in primary care. Early diagnosis reduces mortality; however, how to integrate AI, biomarkers, and mobile apps into resource-constrained polyclinics is unclear. This PRISMA-systematic review is the first to comprehensively analyze the efficacy, safety, and cost-effectiveness of screening for five cancers (breast, colon, lung, stomach, and skin) in primary care. We searched PubMed, eLibrary, and the Cochrane Library for 2021–2026 publications, including RCTs, systematic reviews, and cohort studies, with quality assessment using QUADAS-2 and ROBINS-I. Late diagnosis is the key barrier: in some Russian regions, up to 80% of cases are detected at stages III–IV, versus the national average of ~35% (2023–2024), with several regions substantially exceeding the average rate). The coverage of medical examinations in the regions does not exceed 26.8%. A regional study (Voronezh Oblast) found that 50% of primary care physicians had incorrect knowledge of risk factors; extrapolation to all of Russia is limited. For innovative methods, sensitivity reached up to 95% (low-dose chest CT), and specificity ranged from 84% (AI-based skin applications) to 96.6% (low-dose CT). With a 2% disease prevalence in high-risk groups, the positive predictive value is 22–25%, leaving a false-positive problem (false-positive rates in population screening can reach 75–96%, depending on the cancer site). Cascade algorithms are cost-effective, but published models ignore false-positive costs and psychological harm; moreover, conclusions on cascade effectiveness are based mainly on economic modeling, not randomized clinical trials. Pilot projects show that digital tools (AI platforms and mobile applications) increase the detection of early stages by 1%–8% and screening coverage 2.5-fold. A conceptual personalized screening pathway model was developed and requires further validation. The authors favor systemic restructuring—integrating evidence-based algorithms, workforce strengthening, and digital infrastructure—over fragmented technology adoption. The full text provides a detailed stepwise plan for implementing cascade personalized screening in polyclinics under resource constraints.
- 15 June 2026
- Published by ECO-Vector LLC (Publications) in Russian Family Doctor
- Vol. 30 (2) , 21-34
Open AccessThe use of modern cancer screening methods in primary healthcare
Cancer treatment advances are clear, but screening potential remains underutilized due to deficiencies in primary care. Early diagnosis reduces mortality; however, how to integrate AI, biomarkers, and mobile apps into resource-constrained polyclinics is unclear. This PRISMA-systematic review is the first to comprehensively analyze the efficacy, safety, and cost-effectiveness of screening for five cancers (breast, colon, lung, stomach, and skin) in primary care. We searched PubMed, eLibrary, and the Cochrane Library for 2021–2026 publications, including RCTs, systematic reviews, and cohort studies, with quality assessment using QUADAS-2 and ROBINS-I. Late diagnosis is the key barrier: in some Russian regions, up to 80% of cases are detected at stages III–IV, versus the national average of ~35% (2023–2024), with several regions substantially exceeding the average rate). The coverage of medical examinations in the regions does not exceed 26.8%. A regional study (Voronezh Oblast) found that 50% of primary care physicians had incorrect knowledge of risk factors; extrapolation to all of Russia is limited. For innovative methods, sensitivity reached up to 95% (low-dose chest CT), and specificity ranged from 84% (AI-based skin applications) to 96.6% (low-dose CT). With a 2% disease prevalence in high-risk groups, the positive predictive value is 22–25%, leaving a false-positive problem (false-positive rates in population screening can reach 75–96%, depending on the cancer site). Cascade algorithms are cost-effective, but published models ignore false-positive costs and psychological harm; moreover, conclusions on cascade effectiveness are based mainly on economic modeling, not randomized clinical trials. Pilot projects show that digital tools (AI platforms and mobile applications) increase the detection of early stages by 1%–8% and screening coverage 2.5-fold. A conceptual personalized screening pathway model was developed and requires further validation. The authors favor systemic restructuring—integrating evidence-based algorithms, workforce strengthening, and digital infrastructure—over fragmented technology adoption. The full text provides a detailed stepwise plan for implementing cascade personalized screening in polyclinics under resource constraints.
- Open Access
- 23 January 2026
- Published by Silicea - Poligraf, LLC in Primary Health Care (Russian Federation)
- Vol. 2 (4) , 105-111
Impact of loneliness on mental and clinical status in elderly patients with cardiovascular disease
Aim . To assess potential impact of loneliness syndrome (LS) on mental and clinical status in elderly patients with cardiovascular disease (CVD). Material and methods . A total of 103 elderly patients with CVD were examined, including 51 with LS (study group) and 52 without LS (comparison group). LS was determined using the Russell-Ferguson UCLA Loneliness Scale. The Mini-Mental State Examination, the Geriatric Depression Scale, the General Psychological Well-Being Index, the Insomnia Severity Index, the Epworth Sleepiness Scale, and 10-point visual analogue scales were used. Null hypotheses were rejected at a Type I error Results . In elderly patients with CVD, LS can affect not only their mental but also their clinical status. This syndrome contributes to feelings of anxiety, depression, and daytime sleepiness, negatively impacting self-rated health, mental well-being, and vitality. LS is accompanied by increased headaches, shortness of breath, and peripheral edema. Conclusion . Loneliness is not only a mental but also a medical problem. Its presence in elderly cardiac patients should be considered when managing medical examinations and follow-up.
- 23 January 2026
- Published by Silicea - Poligraf, LLC in Primary Health Care (Russian Federation)
- Vol. 2 (4) , 105-111
Open AccessImpact of loneliness on mental and clinical status in elderly patients with cardiovascular disease
Aim . To assess potential impact of loneliness syndrome (LS) on mental and clinical status in elderly patients with cardiovascular disease (CVD). Material and methods . A total of 103 elderly patients with CVD were examined, including 51 with LS (study group) and 52 without LS (comparison group). LS was determined using the Russell-Ferguson UCLA Loneliness Scale. The Mini-Mental State Examination, the Geriatric Depression Scale, the General Psychological Well-Being Index, the Insomnia Severity Index, the Epworth Sleepiness Scale, and 10-point visual analogue scales were used. Null hypotheses were rejected at a Type I error Results . In elderly patients with CVD, LS can affect not only their mental but also their clinical status. This syndrome contributes to feelings of anxiety, depression, and daytime sleepiness, negatively impacting self-rated health, mental well-being, and vitality. LS is accompanied by increased headaches, shortness of breath, and peripheral edema. Conclusion . Loneliness is not only a mental but also a medical problem. Its presence in elderly cardiac patients should be considered when managing medical examinations and follow-up.
- Open Access
- 24 June 2025
- Published by SCEEMP in Safety and Risk of Pharmacotherapy
- Vol. 13 (2) , 198-212
Local Administration of pCMV-VEGF165 Plasmid Encoding VEGF Stimulates Tissue Regeneration after Cold Injury in Rats
INTRODUCTION. Frostbite is a common cold injury that is associated with high rates of disability and requires long and difficult treatment. A vascular endothelial growth factor (VEGF)-encoding pCMV-VEGF165 plasmid-based gene therapy product designed for therapeutic angiogenesis may be a promising tool to promote microcirculation recovery and accelerate lesion healing in local cold injury. This hypothesis needs to be tested in an experimental animal study.AIM. This study aimed to evaluate the efficacy of the pCMV-VEGF165 plasmid gene therapy product for the management of cold injury of a limb in rats.MATERIALS AND METHODS. The study included 42 mature female outbred white laboratory rats. A third to fourth-degree local cold injury was experimentally induced on the dorsal surface of the left hind paw by applying a neodymium magnet frozen in liquid nitrogen. The animals received periwound injections of the test product (super-coiled circular double-stranded plasmid deoxyribonucleic acid at a dose of 60 μg) and placebo (water for injections) on days 2 and 7 after frostbite modelling. The authors evaluated the general condition of the animals, the condition of the damaged paw, the wound area, the healing rate, the body mass, and, after planned euthanasia, the mass of the hind paws.RESULTS. Starting from day 7, the rats treated with the test product showed significantly faster tissue regeneration at the site of cold injury than the control animals. The mean wound surface area reduction in the test animals amounted to 47.36% [25.55; 55.45], whereas that in the control animals was 28.95±18.55% (pCONCLUSIONS. The pCMV-VEGF165 plasmid gene therapy product injected in the periwound area at a dose of 60 μg on days 2 and 7 after cold injury simulation in rats reduces damage, accelerates tissue regeneration under the scab, and expedites scarring.
- 24 June 2025
- Published by SCEEMP in Safety and Risk of Pharmacotherapy
- Vol. 13 (2) , 198-212
Open AccessLocal Administration of pCMV-VEGF165 Plasmid Encoding VEGF Stimulates Tissue Regeneration after Cold Injury in Rats
INTRODUCTION. Frostbite is a common cold injury that is associated with high rates of disability and requires long and difficult treatment. A vascular endothelial growth factor (VEGF)-encoding pCMV-VEGF165 plasmid-based gene therapy product designed for therapeutic angiogenesis may be a promising tool to promote microcirculation recovery and accelerate lesion healing in local cold injury. This hypothesis needs to be tested in an experimental animal study.AIM. This study aimed to evaluate the efficacy of the pCMV-VEGF165 plasmid gene therapy product for the management of cold injury of a limb in rats.MATERIALS AND METHODS. The study included 42 mature female outbred white laboratory rats. A third to fourth-degree local cold injury was experimentally induced on the dorsal surface of the left hind paw by applying a neodymium magnet frozen in liquid nitrogen. The animals received periwound injections of the test product (super-coiled circular double-stranded plasmid deoxyribonucleic acid at a dose of 60 μg) and placebo (water for injections) on days 2 and 7 after frostbite modelling. The authors evaluated the general condition of the animals, the condition of the damaged paw, the wound area, the healing rate, the body mass, and, after planned euthanasia, the mass of the hind paws.RESULTS. Starting from day 7, the rats treated with the test product showed significantly faster tissue regeneration at the site of cold injury than the control animals. The mean wound surface area reduction in the test animals amounted to 47.36% [25.55; 55.45], whereas that in the control animals was 28.95±18.55% (pCONCLUSIONS. The pCMV-VEGF165 plasmid gene therapy product injected in the periwound area at a dose of 60 μg on days 2 and 7 after cold injury simulation in rats reduces damage, accelerates tissue regeneration under the scab, and expedites scarring.
- 11 April 2025
- Published by Folium Publishing Company in Экспериментальная и клиническая фармакология
- Vol. 88 (3) , 16-21
Агонист имидазолиновых рецепторов I1 – I2 в коррекции проявлений экспериментальной преэклампсии у мышей с мутацией в гене Agouti
Преэклампсия — опасное осложнение беременности, характеризуется эндотелиальной дисфункцией макро- и микрососудистого русла и артериальной гипертензией, что приводит к неблагоприятным последствиям как для матери, так и для плода. Несмотря на существующие методы лекарственного лечения, поиск новых и более эффективных фармакологических веществ остается актуальной задачей. Субстанция С7070 (агонист имидазолиновых рецепторов 1 и 2 типов, 20 мг/кг внутрижелудочно, с 13 по 19 сут гестации) вызывает снижение уровня систолического артериального давления на 18,4 %, до 117,9 ± 1,64 мм рт. ст. (p < 0,05), и диастолического артериального давления — на 26,3 %, до 72,6 ± 1,75 мм рт. ст. (p < 0,05), при экспериментальной преэклампсии у мышей с мутацией в гене Agouti. Отмечено снижение коэффициента эндотелиальной дисфункции с 4,66 ± 0,07 до 1,3 ± 0,03 (p < 0,05) и уровня C-реактивного белка в 2,4 раза (p < 0,05), по сравнению с животными без использования фармакологической поддержки. Кроме того, субстанция С7070 обладает выраженным метаболическим действием, снижая концентрацию глюкозы в крови с 10,3 ± 0,3 до 7,3 ± 0,28 ммоль/л (p < 0,05), концентрацию общего холестерина и триглицеридов — с 3,7 ± 0,12 до 2,7 ± 0,12 ммоль/л (p < 0,05) и с 2,2 ± 0,12 до 1,3 ± 0,09 ммоль/л (p < 0,05), соответственно.
- 11 April 2025
- Published by Folium Publishing Company in Экспериментальная и клиническая фармакология
- Vol. 88 (3) , 16-21
Агонист имидазолиновых рецепторов I1 – I2 в коррекции проявлений экспериментальной преэклампсии у мышей с мутацией в гене Agouti
Преэклампсия — опасное осложнение беременности, характеризуется эндотелиальной дисфункцией макро- и микрососудистого русла и артериальной гипертензией, что приводит к неблагоприятным последствиям как для матери, так и для плода. Несмотря на существующие методы лекарственного лечения, поиск новых и более эффективных фармакологических веществ остается актуальной задачей. Субстанция С7070 (агонист имидазолиновых рецепторов 1 и 2 типов, 20 мг/кг внутрижелудочно, с 13 по 19 сут гестации) вызывает снижение уровня систолического артериального давления на 18,4 %, до 117,9 ± 1,64 мм рт. ст. (p < 0,05), и диастолического артериального давления — на 26,3 %, до 72,6 ± 1,75 мм рт. ст. (p < 0,05), при экспериментальной преэклампсии у мышей с мутацией в гене Agouti. Отмечено снижение коэффициента эндотелиальной дисфункции с 4,66 ± 0,07 до 1,3 ± 0,03 (p < 0,05) и уровня C-реактивного белка в 2,4 раза (p < 0,05), по сравнению с животными без использования фармакологической поддержки. Кроме того, субстанция С7070 обладает выраженным метаболическим действием, снижая концентрацию глюкозы в крови с 10,3 ± 0,3 до 7,3 ± 0,28 ммоль/л (p < 0,05), концентрацию общего холестерина и триглицеридов — с 3,7 ± 0,12 до 2,7 ± 0,12 ммоль/л (p < 0,05) и с 2,2 ± 0,12 до 1,3 ± 0,09 ммоль/л (p < 0,05), соответственно.
- Open Access
- 25 February 2025
- Published by Belgorod National Research University in Research Results in Pharmacology
- Vol. 11 (1) , 90-98
Assessment of the severity of delayed changes in the state of the neuromuscular system during correction of local cold injury of III-IV degree with pCMV-VEGF165 plasmid preparation in an experiment
Introduction: The relevance of the topic is due to a wide range of clinical manifestations of frostbite, including long-term complications such as neuropathy, chronic pain, and functional impairments. Tissue recovery after frostbite depends on the degree of microvascular damage, and VEGF (vascular endothelial growth factor) is considered a promising agent for stimulating angiogenesis and improving tissue trophism. The aim of the study was to study the effectiveness of the use of a genetic construct – pCMV-VEGF165 plasmid in the correction of delayed complications of cold injury in rats. Materials and Methods: Local frostbite of III-IV degree was modeled in 18 rats using a neodymium magnet cooled in liquid nitrogen. On days 2 and 7 after the injury, pCMV-VEGF165 (60 µg) was administered to the wound edges. The control group received a placebo. The state of the neuromuscular system was assessed using electromyography on days 28 and 60. Results and Discussion: In the control group, a significant decrease in the amplitude of the M-response (1.75 times, p=0.001) and an increase in the latency period by 10% (p=0.004) were observed, indicating axonal damage and myelinopathy. The decrement index of the M-response increased (2.2 times), suggesting impaired neuromuscular conduction. In the pCMV-VEGF165 group, the amplitude of the M-response, latency period, and decrement index did not differ significantly from those in the intact animal group. Conclusion: pCMV-VEGF165 promotes a reduction in the degree of tissue damage and accelerates their regeneration by restoring blood flow, confirming its effectiveness in preventing delayed complications of cold injury.
- 25 February 2025
- Published by Belgorod National Research University in Research Results in Pharmacology
- Vol. 11 (1) , 90-98
Open AccessAssessment of the severity of delayed changes in the state of the neuromuscular system during correction of local cold injury of III-IV degree with pCMV-VEGF165 plasmid preparation in an experiment
Introduction: The relevance of the topic is due to a wide range of clinical manifestations of frostbite, including long-term complications such as neuropathy, chronic pain, and functional impairments. Tissue recovery after frostbite depends on the degree of microvascular damage, and VEGF (vascular endothelial growth factor) is considered a promising agent for stimulating angiogenesis and improving tissue trophism. The aim of the study was to study the effectiveness of the use of a genetic construct – pCMV-VEGF165 plasmid in the correction of delayed complications of cold injury in rats. Materials and Methods: Local frostbite of III-IV degree was modeled in 18 rats using a neodymium magnet cooled in liquid nitrogen. On days 2 and 7 after the injury, pCMV-VEGF165 (60 µg) was administered to the wound edges. The control group received a placebo. The state of the neuromuscular system was assessed using electromyography on days 28 and 60. Results and Discussion: In the control group, a significant decrease in the amplitude of the M-response (1.75 times, p=0.001) and an increase in the latency period by 10% (p=0.004) were observed, indicating axonal damage and myelinopathy. The decrement index of the M-response increased (2.2 times), suggesting impaired neuromuscular conduction. In the pCMV-VEGF165 group, the amplitude of the M-response, latency period, and decrement index did not differ significantly from those in the intact animal group. Conclusion: pCMV-VEGF165 promotes a reduction in the degree of tissue damage and accelerates their regeneration by restoring blood flow, confirming its effectiveness in preventing delayed complications of cold injury.
- Open Access
- 22 November 2024
- Published by FSPSI SCFHHRP in Acta Biomedica Scientifica
- Vol. 9 (5) , 114-121
Leukocyte as an adequate model for studying changes in energy metabolism in heart cells under the influence of cardiocytoprotectors in myocardial ischemia
The aim of this study was to determine the possibility of studying the nature of the influence of cardiocytoprotectors on energy metabolism in cardiomyocytes using a model of human peripheral blood leukocytes.Materials and methods. Sixty Wistar rats were divided into groups: 1) intact rats; 2) rats with experimental myocardial ischemia; 3) rats with myocardial ischemia, which were injected with cardiocytoprotector – trimetazidine, 4) meldonium, 5) cytoflavin and 6) ethoxydol. Animals were taken out of the experiment 10 days after the administration of drugs by decapitation. The activities of pyruvate dehydrogenase and citrate synthase were determined in mitochondria of myocardial homogenates and in mitochondria of leukocytes by spectrophotometric methods.Results. The decrease in pyruvate dehydrogenase and citrate synthase activity in cardiomyocytes and in leukocytes were revealed in case of myocardial ischemia modeling. The introduction of cardiocytoprotectors led to the activation of these enzymes both in heart cells and in blood leukocytes. Direct positive correlations were obtained between the activity of pyruvate dehydrogenase in the mitochondria of cardiomyocytes and in the mitochondria of leukocytes (r = 0.811; p < 0.0001); between citrate synthase activity in the mitochondria of cardiomyocytes and in the mitochondria of leukocytes (r = 0.909; p < 0.0001).Conclusion. Changes in energy metabolism in blood leukocytes under the influence of cytoprotectors reflect similar changes occurring in heart cells.
- 22 November 2024
- Published by FSPSI SCFHHRP in Acta Biomedica Scientifica
- Vol. 9 (5) , 114-121
Open AccessLeukocyte as an adequate model for studying changes in energy metabolism in heart cells under the influence of cardiocytoprotectors in myocardial ischemia
The aim of this study was to determine the possibility of studying the nature of the influence of cardiocytoprotectors on energy metabolism in cardiomyocytes using a model of human peripheral blood leukocytes.Materials and methods. Sixty Wistar rats were divided into groups: 1) intact rats; 2) rats with experimental myocardial ischemia; 3) rats with myocardial ischemia, which were injected with cardiocytoprotector – trimetazidine, 4) meldonium, 5) cytoflavin and 6) ethoxydol. Animals were taken out of the experiment 10 days after the administration of drugs by decapitation. The activities of pyruvate dehydrogenase and citrate synthase were determined in mitochondria of myocardial homogenates and in mitochondria of leukocytes by spectrophotometric methods.Results. The decrease in pyruvate dehydrogenase and citrate synthase activity in cardiomyocytes and in leukocytes were revealed in case of myocardial ischemia modeling. The introduction of cardiocytoprotectors led to the activation of these enzymes both in heart cells and in blood leukocytes. Direct positive correlations were obtained between the activity of pyruvate dehydrogenase in the mitochondria of cardiomyocytes and in the mitochondria of leukocytes (r = 0.811; p < 0.0001); between citrate synthase activity in the mitochondria of cardiomyocytes and in the mitochondria of leukocytes (r = 0.909; p < 0.0001).Conclusion. Changes in energy metabolism in blood leukocytes under the influence of cytoprotectors reflect similar changes occurring in heart cells.
- Open Access
- 20 September 2024
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 23 (2S) , 4153
Priority of competencies in the professional activities of general practitioners (family doctors)
The functional responsibilities of general practitioners (family doctors) (GPs) have changed significantly over the past decade. The number of GP functions has expanded. Despite the increasingly complex professional activities of GPs, there is no scientific evidence for the qualification characteristics of GPs expressed in knowledge, skills, abilities, and competencies in the theory and practice in training. In this regard, a study was conducted to determine the priority of GP competencies that make up the qualification characteristics of a specialist. Aim. To analyze, generalize and rationale the research results, as well as to develop preliminary guidelines for GP training. Material and methods. The information base for the study was the results of ranking competencies according to their importance in the professional activities of GPs in Russia. It was obtained during the ascertaining experiment, implemented using the Delphi method as a method of expert assessment and strategic planning of training specialists. Conclusion. The analysis of competencies developed and agreed upon by experts showed its compliance with the job functions of GPs, the requirements of the Federal State Educational Standard for the General Medical Practice (Family Medicine) and the WONCA guidelines. A summary of the study results to determine the priority of competence in GP activities showed the following: — all competencies (25) were defined as necessary and constitutive of GP qualification; — 21 competencies were considered significant and highly significant for GPs; — 4 competencies were considered as of moderate significance and below moderate significance. The analysis of the priority of competences revealed insufficient methodological support for GP training in accordance with the social order. The results obtained showed the need to continue the study within the project "Quality Management of Training of General Practitioners (Family Doctors)".
- 20 September 2024
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 23 (2S) , 4153
Open AccessPriority of competencies in the professional activities of general practitioners (family doctors)
The functional responsibilities of general practitioners (family doctors) (GPs) have changed significantly over the past decade. The number of GP functions has expanded. Despite the increasingly complex professional activities of GPs, there is no scientific evidence for the qualification characteristics of GPs expressed in knowledge, skills, abilities, and competencies in the theory and practice in training. In this regard, a study was conducted to determine the priority of GP competencies that make up the qualification characteristics of a specialist. Aim. To analyze, generalize and rationale the research results, as well as to develop preliminary guidelines for GP training. Material and methods. The information base for the study was the results of ranking competencies according to their importance in the professional activities of GPs in Russia. It was obtained during the ascertaining experiment, implemented using the Delphi method as a method of expert assessment and strategic planning of training specialists. Conclusion. The analysis of competencies developed and agreed upon by experts showed its compliance with the job functions of GPs, the requirements of the Federal State Educational Standard for the General Medical Practice (Family Medicine) and the WONCA guidelines. A summary of the study results to determine the priority of competence in GP activities showed the following: — all competencies (25) were defined as necessary and constitutive of GP qualification; — 21 competencies were considered significant and highly significant for GPs; — 4 competencies were considered as of moderate significance and below moderate significance. The analysis of the priority of competences revealed insufficient methodological support for GP training in accordance with the social order. The results obtained showed the need to continue the study within the project "Quality Management of Training of General Practitioners (Family Doctors)".
- 28 June 2024
- Published by Federal Scientific Center for Hygiene F.F.Erisman in Health Care of the Russian Federation
- Vol. 68 (3) , 226-233
Educational needs of Russian general practitioners: survey results
Introduction. The health of the population largely depends on the availability for a general practitioner (GP) with the knowledge and practical skills necessary to provide high-quality primary health care. Purpose: to study the educational needs, preferred forms, and methods in training Russian GP. Materials and methods. The study was conducted at the Departments of General Medical Practice of the Institute of Vocational Education of Sechenov University, Family Medicine of Belgorod State University, Polyclinic Therapy, Postgraduate Training and Nursing of Kemerovo State Medical University, General Medical Practice and Polyclinic Therapy of the Russian Medical Academy of Continuing Professional Education. The study used sociological, statistical and analytical research methods. The final analysis included four hundred two questionnaires for GP. Results. The disciplines (modules) of the specialty of the therapeutic profile have the greatest practical significance for Russian GP: internal medicine, laboratory and instrumental diagnostics, emergency medical care and oncology. In relation to all disciplines (modules), the need to improve the level of theoretical and practical training was identified. Its main directions are determined. Full-time and part-time forms of education are the most acceptable modes. Most prefer traditional teaching methods. The most convenient is training for 144 hours or short-term thematic educational programs. Research limitations. The limitations of the study are the urban working conditions of the GPs who took part in the survey, as well as subjective assessment, which was the subject of study and analysis. Conclusion. Improving the quality of training in GP will contribute to increasing the satisfaction and motivation of doctors, as well as improving the quality of primary health care and the health in the country’s population.
- 28 June 2024
- Published by Federal Scientific Center for Hygiene F.F.Erisman in Health Care of the Russian Federation
- Vol. 68 (3) , 226-233
Educational needs of Russian general practitioners: survey results
Introduction. The health of the population largely depends on the availability for a general practitioner (GP) with the knowledge and practical skills necessary to provide high-quality primary health care. Purpose: to study the educational needs, preferred forms, and methods in training Russian GP. Materials and methods. The study was conducted at the Departments of General Medical Practice of the Institute of Vocational Education of Sechenov University, Family Medicine of Belgorod State University, Polyclinic Therapy, Postgraduate Training and Nursing of Kemerovo State Medical University, General Medical Practice and Polyclinic Therapy of the Russian Medical Academy of Continuing Professional Education. The study used sociological, statistical and analytical research methods. The final analysis included four hundred two questionnaires for GP. Results. The disciplines (modules) of the specialty of the therapeutic profile have the greatest practical significance for Russian GP: internal medicine, laboratory and instrumental diagnostics, emergency medical care and oncology. In relation to all disciplines (modules), the need to improve the level of theoretical and practical training was identified. Its main directions are determined. Full-time and part-time forms of education are the most acceptable modes. Most prefer traditional teaching methods. The most convenient is training for 144 hours or short-term thematic educational programs. Research limitations. The limitations of the study are the urban working conditions of the GPs who took part in the survey, as well as subjective assessment, which was the subject of study and analysis. Conclusion. Improving the quality of training in GP will contribute to increasing the satisfaction and motivation of doctors, as well as improving the quality of primary health care and the health in the country’s population.
- Open Access
- 17 April 2024
- Published by Belgorod National Research University in Research Results in Pharmacology
- Vol. 10 (2) , 41-47
Study of the neuroprotective properties of the heteroreceptor EPOR/CD131 agonist of peptide structure in tau-proteinopathy modeling
Introduction: Tau proteinopathy is a pathology associated with the activation of post-translational modifications and interactions of pathophysiological cascades of neuroinflammation with hyperphosphorylation of Tau aggregates. Therefore, preference is given to agents that have properties in reducing or slowing down the processes of neuroinflammation and post-translational modifications in the brain. Materials and Methods: The study was conducted on male and female homozygous individuals of a transgenic murine line with overexpression of mutant human Tau gene (P301S) and a background wild mouse line C57Bl/6J. To assess the progression of Tau proteinopathy, behavioral tests were used at two control time points, and the last one measured the level of neuroinflammation markers and tau-proteinopathy. Results and Discussion: In the group of P301S mice treated with ARA-290, an improvement in the phenotypic picture of Tau proteinopathy was demonstrated compared with intact animals. In the Barnes circular maze test, mice showed a decrease in the total distance traveled and the latent time spent on the platform, which indicates a rapid entry into the shelter. In the O-shaped maze test, the group maintained a fairly high level of spontaneous exploratory behavior. In the vertical rod test, the animals recorded the best time indicators that they needed to turn and maintain balance compared to the intact group. A statistically significant decrease in the level of GSK-3β and an increase in CDK5 and PP2A were revealed, which indicates a dephosphorylating effect on Tau protein, as well as markers of neuroinflammation. NF-KB and TNF-α were significantly reduced by 57% and 32%, respectively, compared to the intact group. Conclusion: In the model of transgenic P301S murine line with overexpression of the mutant human Tau gene, the peptide agonist of the EPOR/CD 131 heteroreceptor demonstrated neuroprotective properties, which were confirmed by indicators of behavioral tests and markers of neuroinflammation and tau-proteinopathy. Введение. Таупротеинпатия – патология, связанная с активацией посттранляционных модификаций и за счет взаимодействия патофизиологических каскадов нейровоспаления с гиперфосфорилированием агрегантов Тау. Поэтому отдают предпочтения агентам, у которых есть свойства снижать или замедлять процессы нейровоспаления и посттрансляционные модификации в головном мозге. Материалы и методы: исследование проведено на самцах и самках гомозиготных особей трансгенной линии мышей с гиперэкспрессией мутантного гена Тау человека (P301S) и фоновой дикой линии мышей C57Bl/6J. Для оценки прогрессирования таупротеинпатии применялись поведенческие тесты в двух контрольно-временных точках и на последней измерялся уровень маркеров нейровоспаления и таупротеинпатии. Результаты и их обсуждение: в группе мышей P301S с лечением при помощи ARA-290 продемонстрировала улучшение фенотипической картины таупротеинпатии по сравнению с интактными животными. В тесте круговой лабиринт Барнса у мышей зарегистрировали снижение общего расстояния пройденной дистанции и латентного времени нахождения на платформе, что говорит о быстром заходе в «убежище». В тесте О-образный лабиринт группа сохранила достаточно высокий уровень спонтанного исследовательского поведения. В тесте вертикальный стержень, у животных зарегистрированы лучшие показатели времени, которые им требовались для поворота и для удержания равновесия относительно интактной группы. Статистически значимое снижение уровня GSK-3β и увеличение CDK5 и PP2A, что говорит о дефосфорилирующем действии на белок Тау, а также маркеры нейровоспаления (NF-KB и TNF-α), которые были значительно снижены на 57% и 32% соответственно по сравнению с интактной группой соответственно. Заключение: пептидный агонист гетерорецептора EPOR/CD131 на модели трансгенной линии мышей P301S с гиперэкспрессией мутантного гена Тау человека обладает нейропротективными свойствами, что подтверждается в показателях поведенческих реакций и в определении маркеров нейровоспаления и таупротеинпатии.
- 17 April 2024
- Published by Belgorod National Research University in Research Results in Pharmacology
- Vol. 10 (2) , 41-47
Open AccessStudy of the neuroprotective properties of the heteroreceptor EPOR/CD131 agonist of peptide structure in tau-proteinopathy modeling
Introduction: Tau proteinopathy is a pathology associated with the activation of post-translational modifications and interactions of pathophysiological cascades of neuroinflammation with hyperphosphorylation of Tau aggregates. Therefore, preference is given to agents that have properties in reducing or slowing down the processes of neuroinflammation and post-translational modifications in the brain. Materials and Methods: The study was conducted on male and female homozygous individuals of a transgenic murine line with overexpression of mutant human Tau gene (P301S) and a background wild mouse line C57Bl/6J. To assess the progression of Tau proteinopathy, behavioral tests were used at two control time points, and the last one measured the level of neuroinflammation markers and tau-proteinopathy. Results and Discussion: In the group of P301S mice treated with ARA-290, an improvement in the phenotypic picture of Tau proteinopathy was demonstrated compared with intact animals. In the Barnes circular maze test, mice showed a decrease in the total distance traveled and the latent time spent on the platform, which indicates a rapid entry into the shelter. In the O-shaped maze test, the group maintained a fairly high level of spontaneous exploratory behavior. In the vertical rod test, the animals recorded the best time indicators that they needed to turn and maintain balance compared to the intact group. A statistically significant decrease in the level of GSK-3β and an increase in CDK5 and PP2A were revealed, which indicates a dephosphorylating effect on Tau protein, as well as markers of neuroinflammation. NF-KB and TNF-α were significantly reduced by 57% and 32%, respectively, compared to the intact group. Conclusion: In the model of transgenic P301S murine line with overexpression of the mutant human Tau gene, the peptide agonist of the EPOR/CD 131 heteroreceptor demonstrated neuroprotective properties, which were confirmed by indicators of behavioral tests and markers of neuroinflammation and tau-proteinopathy. Введение. Таупротеинпатия – патология, связанная с активацией посттранляционных модификаций и за счет взаимодействия патофизиологических каскадов нейровоспаления с гиперфосфорилированием агрегантов Тау. Поэтому отдают предпочтения агентам, у которых есть свойства снижать или замедлять процессы нейровоспаления и посттрансляционные модификации в головном мозге. Материалы и методы: исследование проведено на самцах и самках гомозиготных особей трансгенной линии мышей с гиперэкспрессией мутантного гена Тау человека (P301S) и фоновой дикой линии мышей C57Bl/6J. Для оценки прогрессирования таупротеинпатии применялись поведенческие тесты в двух контрольно-временных точках и на последней измерялся уровень маркеров нейровоспаления и таупротеинпатии. Результаты и их обсуждение: в группе мышей P301S с лечением при помощи ARA-290 продемонстрировала улучшение фенотипической картины таупротеинпатии по сравнению с интактными животными. В тесте круговой лабиринт Барнса у мышей зарегистрировали снижение общего расстояния пройденной дистанции и латентного времени нахождения на платформе, что говорит о быстром заходе в «убежище». В тесте О-образный лабиринт группа сохранила достаточно высокий уровень спонтанного исследовательского поведения. В тесте вертикальный стержень, у животных зарегистрированы лучшие показатели времени, которые им требовались для поворота и для удержания равновесия относительно интактной группы. Статистически значимое снижение уровня GSK-3β и увеличение CDK5 и PP2A, что говорит о дефосфорилирующем действии на белок Тау, а также маркеры нейровоспаления (NF-KB и TNF-α), которые были значительно снижены на 57% и 32% соответственно по сравнению с интактной группой соответственно. Заключение: пептидный агонист гетерорецептора EPOR/CD131 на модели трансгенной линии мышей P301S с гиперэкспрессией мутантного гена Тау человека обладает нейропротективными свойствами, что подтверждается в показателях поведенческих реакций и в определении маркеров нейровоспаления и таупротеинпатии.